What sector does Avalo Therapeutics Inc (AVTX) operate in?
Avalo Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Avalo Therapeutics Inc (AVTX) current stock price?
As of the latest data, Avalo Therapeutics Inc stock price is $16.71, with a previous close of $17.10. Avalo Therapeutics Inc lost -$0.39 in the last trading session, representing a -2.28% loss.
What is Avalo Therapeutics Inc (AVTX) current market capitalization?
Avalo Therapeutics Inc market cap is approximately 309.35 million.
What is Avalo Therapeutics Inc (AVTX) Earnings Per Share (EPS)?
The trailing EPS is -$13.42, and the forward EPS is -$4.55.
What is Avalo Therapeutics Inc (AVTX) EBITDA?
Avalo Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -30.55 million.
Does Avalo Therapeutics Inc (AVTX) pay dividends?
No. Avalo Therapeutics Inc does not pay a dividend.
What is Avalo Therapeutics Inc (AVTX) beta (volatility) score?
Avalo Therapeutics Inc has a beta of 0.893, meaning its volatility is roughly in line with the market.